Filter posts

Bioterrorism: Assessing the Threat

Recently, the House of Representatives Homeland Security Committee Subcommittee on Emergency Preparedness, Response, and Communications …

National Health Interview Survey: Adult Vaccination Rates Need Boost

The Centers for Disease Control and Prevention (CDC) recently released immunization coverage estimates from the …

Doping Undermines the Mission of Biotechnology

The Olympic Games in Sochi captures the world’s attention as athletes compete to bring home …

FDA Week: For Biologics, A Name Isn't Just A Name (Jim Greenwood op-ed)

What is in a name? Names help make medicinal products more easily distinguishable by doctors, …

IPAB: Bad Medicine for Patient Care

The Independent Payment Advisory Board is bad medicine for patient care, deficit reduction and containing …

The Hill's Congress Blog: Innovation in medicine isn't optional - it's imperative

Earlier this week, The Hill’s Congress Blog posted an op-ed penned by Andrew von Eschenbach …

Congress Passes Omnibus Spending Agreement

This week, BIO President and CEO Jim Greenwood praised the Congress for passing the fundingbill …

Emerging Company Policy Deconstructed: Fostering Innovation Act (H.R. 2629)

In a nutshell: Representative Michael Fitzpatrick (R-PA) introduced H.R. 2629, the Fostering Innovation Act, to …

National Traceability System Moves into Implementation

Last week, President Obama signed into law the Drug Quality and Security Act (H.R. 3204), …

Emerging Company Policy Deconstructed: Small Cap Liquidity Reform Act (H.R. 3448)

In a nutshell: This bill, sponsored by Reps. Sean Duffy (R-WI) and John Carney (D-DE), …